Sermorelin (CAS 86168-78-7) – Growth Hormone Secretagogue API

Sermorelin (CAS 86168-78-7) is a high-purity synthetic peptide API, acting as a potent growth hormone secretagogue that stimulates the pituitary gland to release endogenous growth hormone (GH). Its amino acid sequence mimics the active fragment of growth hormone-releasing hormone (GHRH), ensuring targeted binding to pituitary receptors with high affinity and minimal off-target effects. Produced via advanced solid-phase peptide synthesis and GMP-compliant processes, it maintains exceptional purity, bioactivity and stability, meeting international pharmaceutical standards for peptide drugs.

This premium API is a key raw material for pharmaceutical manufacturers developing treatments for growth hormone deficiency (GHD) in adults and children. It is also widely applied in formulating products for anti-aging therapies and muscle mass maintenance, supporting metabolic regulation and cellular repair. With proven clinical safety and physiological compatibility, it addresses the demand for natural GH stimulation solutions. For R&D teams and production enterprises, it provides a trusted, high-performance option to advance endocrinology and anti-aging drug development.